Home LiteratureArticle Details
PMID: 2165128 Published · ppublish English Journal Article

Shedding of tumor necrosis factor receptors by activated human neutrophils.

The Journal of experimental medicine ·Vol. 172 ·No. 2 ·1990-08-01 ·Pages 599-607

Porteu F, Nathan C

Abstract

The capacity of human neutrophils (PMN) to bind tumor necrosis factor (TNF) was rapidly lost when the cells were incubated in suspension with agents that can stimulate their migratory and secretory responses. Both physiological (poly)peptides (FMLP, C5a, CSF-GM) and pharmacologic agonists (PMN, calcium ionophore A23187) induced the loss of TNF receptors (TNF-R) from the cell surface. Half-maximal loss in TNF-R ensued after only approximately 2 min with 10(-7) M FMLP at 37 degrees C, and required only 10(-9) M FMLP during a 30-min exposure. However, there were no such changes even with prolonged exposure of PMN to FMLP at 4 degrees or 16 degrees C. Scatchard analysis revealed loss of TNF-binding sites without change in their affinity (Kd approximately 0.4 nM) as measured at incompletely modulating concentrations of FMLP, C5a, PMA, or A23187. The binding of anti-TNF-R mAbs to PMN decreased in parallel, providing independent evidence for the loss of TNF-R from the cell surface. At the same time, soluble TNF-R appeared in the medium of stimulated PMN. This inference was based on the PMN- and FMLP-dependent generation of a nonsedimentable activity that could inhibit the binding of TNF to fresh human PMN or to mouse macrophages, and the ability of mAbs specific for human TNF-R to abolish inhibition by PMN-conditioned medium of binding of TNF to mouse macrophages. Soluble TNF-R activity was associated with a protein of Mr approximately 28,000 by ligand blot analysis of cell-free supernatants of FMLP-treated PMN. Thus, some portion of the FMLP-induced loss of TNF-R from human PMN is due to shedding of TNF-R. Shedding was unaffected by inhibitors of serine and thiol proteases and could not be induced with phosphatidylinositol-specific phospholipase C. Loss of TNF-R from PMN first stimulated by other agents may decrease their responsiveness to TNF. TNF-R shed by PMN may be one source of the TNF-binding proteins found in body fluids, and may blunt the actions of the cytokine on other cells.

MeSH Terms
Biological Factors/pharmacology Chemotactic Factors/pharmacology Cytokines Down-Regulation Growth Substances/pharmacology Humans Kinetics N-Formylmethionine Leucyl-Phenylalanine/pharmacology Neutrophils/drug effects,metabolism,physiology Protease Inhibitors/pharmacology Receptors, Cell Surface/drug effects,isolation & purification,metabolism Receptors, Tumor Necrosis Factor Recombinant Proteins/pharmacology Tumor Necrosis Factor-alpha/metabolism
Chemicals
Biological Factors Chemotactic Factors Cytokines Growth Substances Protease Inhibitors Receptors, Cell Surface Receptors, Tumor Necrosis Factor Recombinant Proteins Tumor Necrosis Factor-alpha N-Formylmethionine Leucyl-Phenylalanine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Porteu F
Department of Medicine, Cornell University Medical College, New York, New York 10021.
Nathan C
References (54)
54 references, click to expand
  1. Release of Ia antigens by a cultured B cell line.
    J Immunol. 1980 May;124(5):2130-6 PMID: 6965967
  2. Regulation of lymphocyte tumor necrosis factor receptors by IL-2.
    J Immunol. 1989 Oct 1;143(7):2236-41 PMID: 2550551
  3. I-Kk and H-2Kk antigens are shed as supramolecular particles in association with membrane lipids.
    J Immunol. 1981 Aug;127(2):482-6 PMID: 6942054
  4. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.
    Anal Biochem. 1981 Apr;112(2):195-203 PMID: 6266278
  5. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils.
    J Exp Med. 1982 Jan 1;155(1):264-75 PMID: 6274994
  6. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.
    J Biol Chem. 1984 May 10;259(9):5430-9 PMID: 6371005
  7. Immunochemical analysis of the released Leu-2 (T8) molecule.
    J Exp Med. 1984 Jul 1;160(1):116-24 PMID: 6203997
  8. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.
    J Immunol. 1985 Sep;135(3):2069-73 PMID: 3926894
  9. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.
    Proc Natl Acad Sci U S A. 1985 Nov;82(22):7626-30 PMID: 2999773
  10. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.
    Nature. 1985 Dec 19-1986 Jan 1;318(6047):665-7 PMID: 3001529
  11. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.
    Proc Natl Acad Sci U S A. 1985 Dec;82(24):8667-71 PMID: 3866246
  12. Stimulation of neutrophils by tumor necrosis factor.
    J Immunol. 1986 Jun 1;136(11):4220-5 PMID: 3009619
  13. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  14. Recombinant tumor necrosis factor causes activation of human granulocytes.
    Blood. 1987 Feb;69(2):640-4 PMID: 3801673
  15. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.
    Lancet. 1987 Feb 14;1(8529):355-7 PMID: 2880163
  16. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.
    J Leukoc Biol. 1987 Mar;41(3):196-204 PMID: 3031189
  17. Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.
    J Immunol. 1987 Aug 1;139(3):855-62 PMID: 3036946
  18. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.
    J Immunol. 1987 Aug 15;139(4):1161-7 PMID: 3038998
  19. The murine lymphocyte receptor for IgE. IV. The mechanism of ligand-specific receptor upregulation on B cells.
    J Immunol. 1987 Aug 15;139(4):1191-8 PMID: 2956326
  20. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.
    J Exp Med. 1987 Oct 1;166(4):1132-7 PMID: 3309124
  21. Binding of tumor necrosis factor alpha (TNF-alpha) to high-affinity receptors on polymorphonuclear cells.
    Exp Hematol. 1987 Nov;15(10):1055-9 PMID: 2822458
  22. Effect of phorbol esters on down-regulation and redistribution of cell surface receptors for tumor necrosis factor-alpha.
    J Biol Chem. 1987 Dec 5;262(34):16450-5 PMID: 2824494
  23. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.
    J Clin Invest. 1987 Dec;80(6):1550-60 PMID: 2445780
  24. Structural and functional roles of glycosyl-phosphatidylinositol in membranes.
    Science. 1988 Jan 15;239(4837):268-75 PMID: 3276003
  25. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.
    Proc Natl Acad Sci U S A. 1988 Jan;85(2):607-11 PMID: 3422444
  26. A monoclonal antibody to a human neutrophil-specific plasma membrane antigen. Effect of the antibody on the C3bi-mediated adherence by neutrophils and expression of the antigen during myelopoiesis.
    J Exp Med. 1988 Feb 1;167(2):421-39 PMID: 2450159
  27. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors.
    Science. 1989 Sep 15;245(4923):1238-41 PMID: 2551036
  28. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.
    J Biol Chem. 1990 Jan 25;265(3):1531-6 PMID: 2153136
  29. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.
    J Exp Med. 1990 Feb 1;171(2):415-26 PMID: 1689365
  30. A serum factor that suppresses the cytotoxic function of cytokine-stimulated human eosinophils.
    J Exp Med. 1990 Mar 1;171(3):681-93 PMID: 2407799
  31. Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents.
    J Exp Med. 1990 Mar 1;171(3):715-27 PMID: 2155279
  32. A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells.
    J Exp Med. 1990 Mar 1;171(3):941-6 PMID: 2307938
  33. Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.
    J Exp Med. 1990 Mar 1;171(3):959-64 PMID: 2137858
  34. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
    Proc Natl Acad Sci U S A. 1990 Apr;87(8):3127-31 PMID: 2158104
  35. Shared actions of endotoxin and taxol on TNF receptors and TNF release.
    Science. 1990 Apr 20;248(4953):370-2 PMID: 1970196
  36. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  37. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.
    Cell. 1988 Apr 8;53(1):45-53 PMID: 3349526
  38. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  39. Water-soluble insulin receptors from human lymphocytes.
    Science. 1972 Oct 13;178(4057):168-9 PMID: 4342623
  40. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
    J Exp Med. 1988 Mar 1;167(3):1171-85 PMID: 2965208
  41. Tumor necrosis factor receptors and cytocidal activity are down-regulated by activators of protein kinase C.
    J Biol Chem. 1988 Apr 25;263(12):5686-92 PMID: 2833510
  42. The PI-linked receptor FcRIII is released on stimulation of neutrophils.
    Nature. 1988 Jun 16;333(6174):667-9 PMID: 2967437
  43. Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line.
    J Biol Chem. 1988 Jul 25;263(21):10262-6 PMID: 2839482
  44. Tumor necrosis, cachexia, shock, and inflammation: a common mediator.
    Annu Rev Biochem. 1988;57:505-18 PMID: 3052281
  45. Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).
    J Exp Med. 1988 Dec 1;168(6):2007-21 PMID: 3199066
  46. A tumor necrosis factor binding protein is present in human biological fluids.
    Eur J Haematol. 1988 Nov;41(5):414-9 PMID: 2850215
  47. Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide.
    J Biol Chem. 1989 Mar 5;264(7):3924-9 PMID: 2537297
  48. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction.
    J Intern Med. 1989 May;225(5):333-6 PMID: 2732671
  49. Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biologic surfaces.
    J Immunol. 1989 Jul 15;143(2):596-602 PMID: 2738405
  50. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor.
    J Biol Chem. 1989 Jul 15;264(20):11966-73 PMID: 2545692
  51. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha).
    J Biol Chem. 1989 Sep 5;264(25):14927-34 PMID: 2549042
  52. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.
    J Cell Biol. 1989 Sep;109(3):1341-9 PMID: 2475511
  53. Antagonistic control of tumor necrosis factor receptors by protein kinases A and C. Enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C.
    J Exp Med. 1989 Sep 1;170(3):947-58 PMID: 2549168
  54. Ligand: a versatile computerized approach for characterization of ligand-binding systems.
    Anal Biochem. 1980 Sep 1;107(1):220-39 PMID: 6254391
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1990-08-01
Pages
599-607
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188336
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]